Novo Nordisk (#NVO) and Amazon Web Services (#AMZN) have entered into a strategic partnership to accelerate drug discovery through AI. The collaboration aims to use advanced AI and cloud technologies to improve research efficiency and accelerate the development of new medicines. Sector: Biotechnology / Cloud Computing / AI Key Highlights 🤝 Novo Nordisk and AWS entered a strategic partnership 🤖 Focused on AI-powered drug discovery ☁️ Leverages Amazon's cloud and AI capabilities 🧬 Aims to accelerate pharmaceutical research and development Why It Matters The partnership highlights the growing role of AI and cloud computing in pharmaceutical R&D, potentially improving the speed and efficiency of drug discovery. Read More: https://www.thinksabio.com/reports/isr/NVO